Surgical Treatment of Acoustic Neuroma: Outcomes and Indications
Overview
Affiliations
Aim: Surgery for acoustic neuroma has developed over the years with a gradual improvement in outcome. The goal of surgery should be cure of the disease and a low morbidity, preserving facial nerve function - and hearing, too, whenever feasible (i.e. in small tumors). The most appropriate approach must be decided case by case.
Background: Results of microsurgery remain heterogeneous, however, probably due to the different amount of experience gained at different centers.
Materials And Methods: Surgical series reported in the recent literature (2012-2015) were critically reviewed, along with some older papers with particularly representative series.
Results And Conclusion: Considering patients' age, surgical morbidity of different approaches, tumor size and hearing, some principles can be identified on which to base surgical indications with a view to achieving the goals of curing the disease with a low morbidity, preserving facial nerve function and hearing, too, whenever feasible (i.e. in patients with small tumors). Different therapeutic approaches are discussed.
Zhang Y, Ge H, Xu M, Mei W J Korean Neurosurg Soc. 2022; 66(2):183-189.
PMID: 36239080 PMC: 10009239. DOI: 10.3340/jkns.2022.0134.
Chiang K, Hsu S, Yang T, Wang M PLoS One. 2021; 16(8):e0253338.
PMID: 34351928 PMC: 8341598. DOI: 10.1371/journal.pone.0253338.
National Trends in Vestibular Schwannoma Surgery: Influence of Patient Characteristics on Outcomes.
Hatch J, Bauschard M, Nguyen S, Lambert P, Meyer T, Mcrackan T Otolaryngol Head Neck Surg. 2018; 159(1):102-109.
PMID: 29584554 PMC: 6712975. DOI: 10.1177/0194599818765717.
CT- and MRI-based gross target volume comparison in vestibular schwannomas.
Kulkarni B, Bajwa H, Chandrashekhar M, Sharma S, Singareddy R, Gudipudi D Rep Pract Oncol Radiother. 2017; 22(3):201-208.
PMID: 28461783 PMC: 5403802. DOI: 10.1016/j.rpor.2017.02.002.
The management of skull base tumours: A challenge claiming for a multidisciplinary collaboration.
Krengli M Rep Pract Oncol Radiother. 2016; 21(4):285-7.
PMID: 27330414 PMC: 4899425. DOI: 10.1016/j.rpor.2016.03.004.